BeyondSpring Inc. Ordinary Shares (BYSI) Stock Price

BYSIStock

$0.72−59.70%52W

Market Cap$29.61M

P/E—

PEG Ratio—

Div yield—

Beta-0.25

BYSI Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-57.52%

Price vs S&P 500 (4W)-43.20%

VGM Score26.61

Book Value / Share (Quarterly)$0.21

Indicated Dividend (Annual)$0.00

Cash Flow / Share (Quarterly)$-0.46

Price vs S&P 500 (YTD)-68.45%

Net Profit Margin (TTM)-4750.48%

EPS (TTM)$-0.19

10-Day Avg Trading Volume4.05M

EPS Excl Extra (TTM)$-0.19

EPS (Annual)$-0.02

ROI (Annual)-227.16%

Net Profit Margin (5Y Avg)-9233.73%

Cash / Share (Quarterly)$0.19

ROA (Last FY)-3.88%

EBITD / Share (TTM)$-0.21

ROE (5Y Avg)-174.61%

Operating Margin (TTM)-4903.03%

Cash Flow / Share (Annual)$-0.48

P/B Ratio4.63x

P/B Ratio (Quarterly)6.92x

Net Income / Employee (Annual)$-22,900

EV / Revenue (TTM)24.80x

Net Interest Coverage (TTM)-236.00x

ROA (TTM)-29.15%

EPS Incl Extra (Annual)$-0.02

Current Ratio (Annual)1.54x

Quick Ratio (Quarterly)1.06x

3-Month Avg Trading Volume0.47M

52-Week Price Return-59.70%

Revenue / Employee (TTM)$0

Tangible BV / Share (Quarterly)$-0.15

P/S Ratio (Annual)27.79x

Asset Turnover (Annual)0.03x

52-Week High$2.44

Operating Margin (5Y Avg)-9191.78%

EPS Excl Extra (Annual)$-0.02

CapEx CAGR (5Y)-0.78%

26-Week Price Return-46.27%

Quick Ratio (Annual)1.52x

13-Week Price Return-50.75%

Total Debt / Equity (Annual)0.06x

Current Ratio (Quarterly)1.09x

Enterprise Value$33.51M

Asset Turnover (TTM)0.01x

Revenue / Employee (Annual)$0

Pretax Margin (Annual)-2673.35%

Cash / Share (Annual)$0.31

3-Month Return Std Dev108.55%

Net Income / Employee (TTM)$-173,700

ROE (Last FY)-240.51%

Net Interest Coverage (Annual)-29.23x

EPS Basic Excl Extra (Annual)$-0.02

Receivables Turnover (TTM)0.00x

Total Debt / Equity (Quarterly)0.06x

EPS Incl Extra (TTM)$-0.19

ROI (TTM)-128.17%

P/S Ratio (TTM)27.79x

Pretax Margin (5Y Avg)-9104.20%

Revenue / Share (Annual)$0.00

Tangible BV / Share (Annual)$-0.15

Forward P/E0.36x

Price vs S&P 500 (52W)-78.02%

Year-to-Date Return-56.49%

5-Day Price Return-1.24%

EPS Normalized (Annual)$-0.02

ROA (5Y Avg)-54.33%

Net Profit Margin (Annual)-2463.29%

Month-to-Date Return-38.33%

EBITD / Share (Annual)$-0.22

Operating Margin (Annual)-2756.40%

LT Debt / Equity (Annual)0.00x

ROI (5Y Avg)-170.11%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-0.19

P/B Ratio (Annual)6.64x

Pretax Margin (TTM)-4784.46%

Book Value / Share (Annual)$0.69

Price vs S&P 500 (13W)-53.54%

Beta-0.25x

Revenue / Share (TTM)$0.00

ROE (TTM)-133.13%

52-Week Low$0.67

vGradeD

mGradeD

vgmGradeD

BYSI Analyst Recommendations

Mar 2024

Apr 2024

May 2024

Jun 2024

4.29

Industry Peers — Pharmaceuticals(571)

Symbol	Value Score	Growth Score	Momentum Score	Price
BYSIBeyondSpring Inc. Ordinary Shares	D	—	D	$0.72
LLYEli Lilly & Co.	D	B	B	$1233.66
JNJJohnson & Johnson	D	C	B	$273.14
ABBVABBVIE INC.	D	C	B	$265.79
MRKMerck & Co., Inc.	D	C	A	$156.45
NVSNovartis AG	C	C	C	$159.98
AZNAstraZeneca PLC	C	B	C	$169.66
NVONovo-Nordisk A/S	B	C	C	$48.66
ABTAbbott Laboratories	C	C	B	$116.13
PFEPfizer Inc.	C	D	C	$28.57
VRTXVertex Pharmaceuticals Inc	D	C	B	$552.85
BMYBristol-Myers Squibb Co.	B	B	B	$67.92
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	C	C	$46.02
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	B	C	C	$52.07
REGNRegeneron Pharmaceuticals Inc	C	C	B	$833.56
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	C	$18.35
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$38.10
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	C	$376.37
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	B	$62.07
ALNYAlnylam Pharmaceuticals, Inc.	D	A	D	$240.08
ZTSZOETIS INC.	B	C	D	$77.29
INSMInsmed, Inc.	F	A	C	$123.89
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	$36.47
UTHRUnited Therapeutics Corp	C	C	C	$518.53
GMABGenmab A/S ADS	C	C	B	$34.36
VTRSViatris Inc. Common Stock	B	C	B	$16.72
JAZZJazz Pharmaceuticals, Inc.	B	C	B	$260.23
ASNDAscendis Pharma A/S Ordinary Share	D	A	C	$252.99
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	$80.40
CORTCorcept Therapeutics Inc.	F	C	A	$123.57
BMRNBioMarin Pharmaceuticals Inc	C	C	C	$66.12
ARWRArrowhead Research Corporation	D	A	B	$88.88
ELANElanco Animal Health Incorporated Common Stock	C	B	B	$25.09
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	C	$512.16
CYTKCytokinetics Inc.	F	D	B	$77.46
AXSMAxsome Therapeutics, Inc	D	B	C	$205.48
SMMTSummit Therapeutics Inc. Common Stock	F	—	D	$13.36
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	$63.57
ABVXAbivax SA American Depositary Shares	—	—	C	$117.93
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	D	C	$12.34
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	$368.02
NUVLNuvalent, Inc. Class A Common Stock	—	—	B	$123.96
PTGXProtagonist Therapeutics, Inc	F	B	A	$150.59
SYRESpyre Therapeutics, Inc. Common Stock	—	—	A	$107.36
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	$84.86
TGTXTG Therapeutics, Inc.	D	B	A	$55.42
ALKSAlkermes Inc. plc	D	C	B	$49.21
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	$113.35
ORKAOruka Therapeutics, Inc. Common Stock	F	—	A	$101.82
BLTEBelite Bio, Inc American Depositary Shares	—	—	B	$161.68
COGTCogent Biosciences, Inc. Common Stock	F	—	B	$36.80

About BeyondSpring Inc. Ordinary Shares

BeyondSpring Inc is a clinical-stage biopharmaceutical company developing cancer therapies with a focus on immuno-oncology. The company's lead program, Plinabulin, is an investigational agent in clinical development for oncology indications.